Option Market Alert: Adaptimmune Therapeutics PLC Implied Price Swing Hits An Escalated Level – CML News

This article was originally published on this site

Risk Alert: Before we dive into any analysis we simply note that Adaptimmune Therapeutics PLC (NASDAQ:ADAP) risk is elevated. We’ll detail it below — but that’s the lede — the option market is starting to flash those neon lights that signal “risk is rising” with an IV30 of 92.83% versus the IV30 of the S&P 500 at 8.63%. The annual high for Adaptimmune Therapeutics PLC IV30 is 121.63%.

To skip ahead of this risk alert and see if buying or selling options has been a winner in Adaptimmune Therapeutics PLC, you can go here: Getting serious about option trading.

This is a proprietary risk rating and risk alert system that looks forward for the next month — or really 30 days to be exact — and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for Adaptimmune Therapeutics PLC (NASDAQ:ADAP) . The creator of this model is Capital Market Laboratories (CMLviz.com).

Powered by WPeMatico